Johan M. Spoor was the founder of Entero Therapeutics, Inc. (2014) and served as Director from 2019 to 2020. Current jobs include President, Chief Executive Officer & Director at FluoroPharma, Inc. since 2011, Chief Executive Officer & Director at Perspective Therapeutics, Inc. since 2023, Independent Director at AtheroNova, Inc. since 2012, Director at AeacusBio, and Director at Verifi Water, Inc. Former jobs include Chief Executive Officer & Director at IsoRay, Inc., Chief Executive Officer at Viewpoint Molecular Targeting, Inc. from 2022 to 2023, President & Chief Executive Officer at KBP Biosciences USA, Inc. from 2019 to 2021, Director at Photovoltaic Solar Cells, Inc. in 2012, Director at FluoroPharma Medical, Inc. in 2015, Independent Director at Protea Biosciences Group, Inc. in 2014, Independent Director at MetaStat, Inc. from 2015 to 2016, Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2005 to 2007, Research Analyst at JPMorgan Securities LLC from 2007 to 2008, and Chief Financial Officer at Sunstone Biosciences, Inc. Education includes an undergraduate degree from the University of Toronto (1994) and an MBA from Columbia Business School.
What is Johan M. Spoor's net worth?
The estimated net worth of Johan M. Spoor is at least $141.93 thousand as of March 28th, 2025. Mr. Spoor owns 59,383 shares of Perspective Therapeutics stock worth more than $141,925 as of December 4th. This net worth estimate does not reflect any other assets that Mr. Spoor may own. Additionally, Mr. Spoor receives a salary of $855,780.00 as CEO at Perspective Therapeutics. Learn More about Johan M. Spoor's net worth.
How old is Johan M. Spoor?
Mr. Spoor is currently 52 years old. There are 2 older executives and no younger executives at Perspective Therapeutics. The oldest executive at Perspective Therapeutics is Dr. Markus Puhlmann M.B.A., M.D., Chief Medical Officer, who is 58 years old. Learn More on Johan M. Spoor's age.
What is Johan M. Spoor's salary?
As the CEO of Perspective Therapeutics, Inc., Mr. Spoor earns $855,780.00 per year. The highest earning executive at Perspective Therapeutics is Mr. Jonathan R. Hunt, CFO and Principal Financial & Accounting Officer, who commands a salary of $944,350.00 per year. Learn More on Johan M. Spoor's salary.
How do I contact Johan M. Spoor?
Has Johan M. Spoor been buying or selling shares of Perspective Therapeutics?
Johan M. Spoor has not been actively trading shares of Perspective Therapeutics in the last ninety days. Most recently, on Friday, March 28th, Johan M. Spoor bought 22,026 shares of Perspective Therapeutics stock. The stock was acquired at an average cost of $2.24 per share, with a total value of $49,338.24. Following the completion of the transaction, the chief executive officer now directly owns 59,383 shares of the company's stock, valued at $133,017.92. Learn More on Johan M. Spoor's trading history.
Who are Perspective Therapeutics' active insiders?
Are insiders buying or selling shares of Perspective Therapeutics?
In the last twelve months, Perspective Therapeutics insiders bought shares 8 times. They purchased a total of 170,169 shares worth more than $428,783.18. The most recent insider tranaction occured on November, 13th when CAO Jonathan Robert Hunt bought 11,000 shares worth more than $22,330.00. Insiders at Perspective Therapeutics own 3.7% of the company.
Learn More about insider trades at Perspective Therapeutics. Information on this page was last updated on 11/13/2025.
